|
|
 |
|
Viewing report
|
|
|
|
Antares Pharma, Inc.: SWOT Analysis & Company Profile
Business Review, April 2010, Pages: 23
Synopsis
Business Review’s Antares Pharma, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Antares Pharma, Inc.’s business.
Business Review’s “Antares Pharma, Inc. SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Antares Pharma, Inc.) for business intelligence requirements
- Studies and presents Antares Pharma, Inc.’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Antares Pharma, Inc. (Antares Pharma) is a specialty pharmaceutical company engaged in the development and commercialization of novel parenteral therapeutic products using advanced drug delivery systems. The company is focused on self-injection pharmaceutical products and technologies and topical gel-based products. The company has developed three proprietary platforms. Its subcutaneous injection technology platforms include Vision, reusable needle-free injectors; Vibex, disposable pressure-assisted auto injectors and disposable multi-use pen injectors. Antares Pharma applies its drug delivery systems in collaborations with pharmaceutical partners to enhance its partners' drug compounds. It has various multiple development partnerships with leading pharmaceutical companies. The company has a parenteral products division in Minneapolis, Minnesota. Antares Pharma is headquartered at Ewing in New Jersey, the US.
|
|
|
|
